DiaMedica Therapeutics Inc.
DMAC | NASDAQ
$7.42
+$0.16 (+2.20%)
Sep 22, 2026, 11:45 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -11.37 | -9.05 | -4.73 | -3.04 | -5.74 | -13 |
PEG Ratio | -0.68 | n/a | -0.31 | 0.15 | 0.34 | 1.05 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 6.66 | 5.39 | 1.81 | 1.31 | 1.76 | 6.11 |
P/FCF Ratio | -12.85 | -9.93 | -4.93 | -3.60 | -6.31 | -17.22 |
P/OCF Ratio | -12.87 | -9.94 | -4.94 | -3.63 | -6.32 | -17.31 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Quick Ratio | 11.81 | 8.28 | 19.27 | 15.61 | 29.82 | 13.77 |
Current Ratio | 11.81 | 8.28 | 19.27 | 15.61 | 29.82 | 13.77 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -58.40% | -60.03% | -37.96% | -42.97% | -30.87% | -47.25% |
Return on Assets | -53.39% | -52.74% | -35.78% | -39.76% | -29.84% | -43.75% |
Return on Invested Capital | -61.04% | -64.98% | -41.33% | -43.35% | -30.96% | -48.60% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DMAC